CPA
IBB icon

Cardiff Park Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Cardiff Park Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.27K Hold
37
– – ﹤0.01% 363
2025
Q4 		$6.26K Sell
37
-100
-73% -$16.2K ﹤0.01% 342
2025
Q3 		$19.8K Sell
137
-25
-15% -$3.41K ﹤0.01% 353
2025
Q2 		$20.5K Buy
162
+125
+338% +$15.3K ﹤0.01% 327
2025
Q1 		$4.74K Buy
+37
New +$5.02K ﹤0.01% 344
2022
Q3 		– Sell
-249
Closed -$29K – 326
2022
Q2 		$29K Hold
249
– – ﹤0.01% 286
2022
Q1 		$32K Hold
249
– – ﹤0.01% 288
2021
Q4 		$38K Buy
+249
New +$38.6K 0.01% 280

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cardiff Park Advisors's IBB Position: Q1 2026 in Review

Cardiff Park Advisors held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 37 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Cardiff Park Advisors first reported a position in IBB in Q4 2021 and has held it in 8 quarters since. The position peaked at $38K in Q4 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Cardiff Park Advisors held 37 shares of iShares Biotechnology ETF worth $6.27K as of Q1 2026.
  • Cardiff Park Advisors left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Cardiff Park Advisors's portfolio in Q1 2026, its #363 holding.
  • Cardiff Park Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 8 quarters since.
  • Cardiff Park Advisors's iShares Biotechnology ETF position peaked at $38K in Q4 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.